Tristel, the manufacturer of infection control, contamination control and hygiene products, raised £3.9 million via the private placement of 6,842,105 shares at 57p.

The money has been raised in order to reduce bank borrowings, restructure royalty payments related to its chlorine dioxide chemistry, and expand into new global markets. As part of the plan, Tristel will double the existing manufacturing capacity and build a clean room facility at the company’s Snailwell facility in Cambridgeshire - providing the ability to manufacture sterile packed products for the pharmaceuticals, cosmetics and toiletries industries.

Tristel plans to hold an EGM on the 22nd of November to approve the placing.

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here